RHA Redensity Eye

RHA Redensity Eye is an injectable dermal filler developed by TEOXANE SA and distributed in the U.S. by Revance Therapeutics. It is a sterile, biodegradable, viscoelastic gel composed of cross-linked hyaluronic acid (15 mg/g) and 0.3% lidocaine. The product is manufactured using TEOXANE's proprietary Preserved Network Technology (PNT), a gentle, heatless process designed to preserve the natural long-chain structure of hyaluronic acid, allowing the filler to adapt to the delicate and dynamic movements of the infraorbital area. It is FDA-approved for the correction of moderate to severe tissue volume deficiencies in the infraorbital region (undereye hollows) in adults aged 22 years or older, with clinical results demonstrated to last up to 12 months.

Brand names

RHA Redensity EyeTeosyal RHA Redensity 2

Other names

RHA RedensityTeosyal RHA Redensity IIResilient Hyaluronic Acid Redensity Eye